PCK 0.00% 3.0¢ painchek ltd

Ann: Quarterly Investor Update Presentation, page-13

  1. 388 Posts.
    lightbulb Created with Sketch. 85
    Not sure... I have always thought Painchek is trying to balance between a patient centric healthcare company vs a for profit hype micro-cap company. It has certainly leaned towards the former at the detriment of abysmal TSR for the past 2.5 years.

    That said though.. I don't like the 4C update on assessments # vs the presentation.. the 4C commentary stipulated a much higher assessments done in the quarter vs what is shown on the investor presentation.. it's either misleading on intention or unprofessional in its proof reading.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.